Related Experiment Video
Updated: Aug 17, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Cervical screening and human papillomavirus
1Scone, New South Wales, Australia. bsheary@sconemedical.com
Background:
Cervical screening in Australia has been successful in reducing the incidence and mortality of cervical cancer. Human papilloma virus (HPV) is a common sexually transmitted infection and an integral agent in the development of cervical cancer.
Objective:
This article discusses cervical screening, HPV infection and counselling women with low grade abnormalities on cervical cytology.
Discussion:
For most women, detectable HPV infection is transient and subclinical. While HPV is a precursor to cervical cancer, this is a rare outcome of HPV infection. Minor abnormalities on cervical cytology reflecting acute HPV infection are common. Women with low grade Pap test abnormalities require reassurance and education about the prevalence and natural history of HPV.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Human Virome
Genital Herpes
Cytomegalovirus Disease
Sexually Transmitted Infections